Valeant sees 'unrivaled' growth in possible Allergan merger
April 21 (Reuters) - A merger between Valeant Pharmaceuticals International Inc and Allergan Inc would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday.
Valeant will finalize and announce terms of its proposal shortly, the spokesperson said. (Reporting by Rod Nickel. Editing by Andre Grenon)
© Thomson Reuters 2017 All rights reserved.